Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria
- PMID: 35336016
- PMCID: PMC8950055
- DOI: 10.3390/pharmaceutics14030642
Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria
Abstract
Bacterial resistance is an emergency public health problem worldwide, compounded by the ability of bacteria to form biofilms, mainly in seriously ill hospitalized patients. The World Health Organization has published a list of priority bacteria that should be studied and, in turn, has encouraged the development of new drugs. Herein, we explain the importance of studying new molecules such as antimicrobial peptides (AMPs) with potential against multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteria and focus on the inhibition of biofilm formation. This review describes the main causes of antimicrobial resistance and biofilm formation, as well as the main and potential AMP applications against these bacteria. Our results suggest that the new biomacromolecules to be discovered and studied should focus on this group of dangerous and highly infectious bacteria. Alternative molecules such as AMPs could contribute to eradicating biofilm proliferation by MDR/XDR bacteria; this is a challenging undertaking with promising prospects.
Keywords: MDR bacteria; antimicrobial peptides; antimicrobial resistance; biofilm; drug discovery; extensive drug resistance.
Conflict of interest statement
All contributing authors declare no conflict of interest.
Figures
References
-
- WHO . Critically Important Antimicrobials for Human Medicine: Ranking of Antimicrobial Agents for Risk Management of Antimicrobial Resistance due to Non-Human Use. 5th ed. World Health Organization; Geneva, Switzerland: 2017.
-
- Magana M., Pushpanathan M., Santos A.L., Leanse L., Fernandez M., Ioannidis A., Giulianotti M.A., Apidianakis Y., Bradfute S., Ferguson A.L., et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect. Dis. 2020;20:e216–e230. doi: 10.1016/S1473-3099(20)30327-3. - DOI - PubMed
Publication types
Grants and funding
- 2020/13497-4/São Paulo Research Foundation
- 2020/16573-3/São Paulo Research Foundation
- 429139/2018-7/National Council for Scientific and Technological Development
- 404181/2019-8/National Council for Scientific and Technological Development
- 303603/2018-6/National Council for Scientific and Technological Development
LinkOut - more resources
Full Text Sources